PMS-PREGABALIN: Affected lot may contain empty capsules.
Brand(s)
Last updated
Summary
Product
PMS-PREGABALIN
Issue
Health products - Product quality
Health products - Product safety
What to do
Consult your health care professional if you have any health concerns.
Distribution
National
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
PMS |
PMS-PREGABALIN |
DIN 02359618 |
Capsule |
PREGABALIN 50mg |
653166 |
Issue
The affected lot may contain empty capsules.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers, Wholesalers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
PHARMASCIENCE INC
6111 Royalmount Ave, suite 100
Montreal, QC
H4P 2T4
Published by
Health Canada
Audience
General public
Health professionals
Industry
Distribution
National
Recall class
Type II
Identification number
RA-76513
Get notified
Receive notifications for new and updated recalls and alerts by category.